These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 65207)

  • 21. Immunity to tumor-associated antigens in vasectomized men.
    Anderson DJ; Alexander NJ; Fulgham DL; Vandenbark AA; Burger DR
    J Natl Cancer Inst; 1982 Sep; 69(3):551-5. PubMed ID: 6180209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-associated immunity and serum blocking by radioisotopic leukocyte adherence inhibition assay.
    Tsang PH; Holland JF; Bekesi JG
    Mt Sinai J Med; 1985 Mar; 52(3):193-200. PubMed ID: 3887140
    [No Abstract]   [Full Text] [Related]  

  • 23. Demonstration of tube leukocyte adherence inhibition assay with coded samples of blood.
    Thomson DM
    Cancer Res; 1979 Feb; 39(2 Pt 2):627-9. PubMed ID: 83917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Organ specific neoantigens reactive in the leukocyte adherence inhibition assay: affinity purification of human colon carcinoma antigen and its cross-reactive protein using monoclonal antibodies.
    Hadas E; Fink A; Gembom E; Harpaz N; Shani A; Bentwich Z; Eshhar Z
    Cancer Res; 1986 Oct; 46(10):5201-5. PubMed ID: 2428475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer.
    Tsang PH; Holland JF; Bekesi JG
    J Clin Lab Immunol; 1982 Dec; 9(3):151-7. PubMed ID: 6762442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemocytometer leukocyte adherence inhibition technique.
    Maluish AE; Halliday WJ
    Cancer Res; 1979 Feb; 39(2 Pt 2):625-6. PubMed ID: 83916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The natural history of antitumour immunity in human breast cancer assayed by tube leucocyte adherence inhibition.
    Lopez M; O'Connor R; MacFarlane JK; Thomson DM
    Br J Cancer; 1978 Dec; 38(6):660-73. PubMed ID: 369585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive value of tube leukocyte adherence inhibition (LAI) assay for breast, colorectal, stomach and pancreatic cancer.
    MacFarlane JK; Thomson DM; Phelan K; Shenouda G; Scanzano R
    Cancer; 1982 Mar; 49(6):1185-93. PubMed ID: 7037158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A leukocyte adherence inhibition (LAI) assay of anti-tumor immunity in rats using selective radioimmunological assessment of adherence of T lymphocytes and monocytes.
    Morizane T; Sjögren HO
    Int J Cancer; 1983 Jun; 31(6):803-12. PubMed ID: 6345408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leukocyte adherence inhibition in patients with nonmalignant disorders of the colon and colorectal cancer.
    Tank B; Marquet RL; Vennemans E; Westbroek DL
    J Cancer Res Clin Oncol; 1986; 112(3):276-80. PubMed ID: 3782265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression by human fetal organs of organ-specific cancer neoantigens as measured by leukocyte adherence inhibition.
    Gubersky M; Thomson DM; Lajzerowicz M
    Cancer Immunol Immunother; 1986; 21(2):107-13. PubMed ID: 3633212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
    Okada Y
    Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of the leukocyte adherence inhibition (LAI), CA 19-9, and tissue polypeptide antigen (TPA) tests in the diagnosis of pancreatic cancer.
    Meduri F; Doni MG; Merenda R; Bizzarini M; Neri D; Gerunda GE; Maffei Faccioli A
    Cancer; 1989 Sep; 64(5):1103-6. PubMed ID: 2667748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leukocyte adherence inhibition (LAI) for detecting specific tumor immunity in colorectal cancer.
    Fink A; Shani A; Weisman Z; Wechsler U; Pfeffermann R; Harpaz N; Eitan S; Bentwich Z
    Immunol Lett; 1985; 9(2-3):143-7. PubMed ID: 3886534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experiences with leukocyte adherence inhibition in human cancer.
    Maluish AE
    Cancer Res; 1979 Feb; 39(2 Pt 2):644-8. PubMed ID: 367590
    [No Abstract]   [Full Text] [Related]  

  • 36. Assessment of the mechanism of the leukocyte adherence inhibition test.
    Tong AW; Burger DR; Finke P; Barney C; Vandenbark AA; Vetto RM
    Cancer Res; 1979 Feb; 39(2 Pt 2):597-603. PubMed ID: 367586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of different states of immunity to colon cancer in rats by a leukocyte adherence inhibition (LAI) assay assessing the adherence of T lymphocytes and monocytes selectively.
    Morizane T; Sjögren HO
    Int J Cancer; 1983 Jun; 31(6):813-6. PubMed ID: 6345409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of cell-mediated immune reactivity of breast cancer patients by the leukocyte adherence inhibition response to MCF-7 extracts.
    Rudczynski AB; Dyer CA; Mortensen RF
    Cancer Res; 1978 Nov; 38(11 Pt 1):3590-4. PubMed ID: 81103
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of serum factors and cell washings on leukocyte adherence inhibition in breast cancer patients.
    Fujisawa T; Waldman SR; Yonemoto RH
    Gan; 1980 Apr; 71(2):165-72. PubMed ID: 7009300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leukocyte adherence inhibition (LAI) test, LAI. Trypsin and LAI. Humoral test in large term immunotherapy with levamisole on breast and colon cancer.
    De Carli HO; Restbergs V
    Rev Esp Oncol; 1983; 30(1):25-39. PubMed ID: 6387830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.